An update to SPIRIT and CONSORT reporting guidelines to enhance transparency in randomized trials
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Harmonising the reporting process should improve usability and adherence, and lead to more-complete reporting [17].”
From CONSORT 2025 statement: Updated guideline for reporting randomised trials (2025) · cites this paper as [17]
In the citing paper
“Development of reporting standards is an ongoing process, and some are now being harmonized through initiatives such as the MDAR Checklist (Materials, Design, Analysis, and Reporting) [24,25] and the alignment of guidelines for reporting trial protocols (SPIRIT) and results (CONSORT) [26].”
From Open Science 2.0: Towards a truly collaborative research ecosystem (2023) · cites this paper as [26]
In the citing paper
“Harmonising the reporting recommendations could help improve usability and adherence.18”
From SPIRIT 2025 statement: updated guideline for protocols of randomised trials (2025) · cites this paper as [18]
In the citing paper
“Harmonising the reporting process should improve usability and adherence, and lead to more-complete reporting.17”
From CONSORT 2025 statement: updated guideline for reporting randomised trials (2025) · cites this paper as [17]
In the citing paper
“Updating the SPIRIT and CONSORT statements together was also an opportunity to align reporting in both checklists and to provide users with consistent guidance in the reporting of trial design, conduct, and analysis, from the trial protocol to final publication.”
From CONSORT 2025 statement: updated guideline for reporting randomised trials (2025) · cites this paper as [17]
Citations
Cites
Hoffmann, T. C., Glasziou, P. P., Boutron, I., Milne, R., Perera, R., Moher, D., Altman, D. G., Barbour, V., Macdonald, H., Johnston, M., et al. (2014) · BMJ · doi:10.1136/bmj.g1687 · Cited by 10,548
Self-citationCONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group (2010) · BMJ · doi:10.1136/bmj.c332 · Cited by 9,329
Self-citationMoher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883
Self-citationSPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
Chan, A.-W., Tetzlaff, J. M., Altman, D. G., Laupacis, A., Gøtzsche, P. C., Krleža-Jerić, K., Hróbjartsson, A., Mann, H., Dickersin, K., Berlin, J. A., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-3-201302050-00583 · Cited by 7,363
Self-citationSPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
Chan, A.-W., Tetzlaff, J. M., Gotzsche, P. C., Altman, D. G., Mann, H., Berlin, J. A., Dickersin, K., Hrobjartsson, A., Schulz, K. F., Parulekar, W. R., et al. (2013) · BMJ · doi:10.1136/bmj.e7586 · Cited by 6,251
Self-citationImproving the Quality of Reporting of Randomized Controlled Trials: The CONSORT Statement
Begg, C. (1996) · JAMA · doi:10.1001/jama.1996.03540080059030 · Cited by 3,127
Moher, D. (2001) · JAMA · doi:10.1001/jama.285.15.1987 · Cited by 2,545
Self-citationIncreasing value and reducing waste in research design, conduct, and analysis
Ioannidis, J. P. A., Greenland, S., Hlatky, M. A., Khoury, M. J., Macleod, M. R., Moher, D., Schulz, K. F., & Tibshirani, R. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62227-8 · Cited by 1,597
Self-citationBetter Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
Ioannidis, J. P. A., Evans, S. J. W., Gøtzsche, P. C., O'Neill, R. T., Altman, D. G., Schulz, K., Moher, D., & for the CONSORT Group* (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00009 · Cited by 1,593
Self-citationGuidance for Developers of Health Research Reporting Guidelines
Moher, D., Schulz, K. F., Simera, I., & Altman, D. G. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000217 · Cited by 1,437
Self-citation
Research works printed but not linked: 1
- Kapp, P. et al. Preprint at https://www.medrxiv.org/content/10.1101/2022.02.03.22270357v1 (2022). · doi:10.1101/2022.02.03.22270357v1
Cited by
CONSORT 2025 statement: updated guideline for reporting randomised trials
Hopewell, S., Chan, A.-W., Collins, G. S., Hróbjartsson, A., Moher, D., Schulz, K. F., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., et al. (2025) · BMJ · doi:10.1136/bmj-2024-081123 · Cited by 1,195
“17 Thus, clear and transparent reports of trial protocols should in turn facilitate properly designed and well conducted trials.”
Self-citationCONSORT 2025 statement: updated guideline for reporting randomised trials
Hopewell, S., Chan, A.-W., Collins, G. S., Hróbjartsson, A., Moher, D., Schulz, K. F., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00672-5 · Cited by 510
“17 Thus, clear and transparent reports of trial protocols should in turn facilitate properly designed and well conducted trials.”
Self-citationSPIRIT 2025 statement: updated guideline for protocols of randomised trials
Chan, A.-W., Boutron, I., Hopewell, S., Moher, D., Schulz, K. F., Collins, G. S., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., et al. (2025) · BMJ · doi:10.1136/bmj-2024-081477 · Cited by 460
Self-citationCONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials
Hopewell, S., Chan, A.-W., Collins, G. S., Hróbjartsson, A., Moher, D., Schulz, K. F., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., et al. (2025) · JAMA · doi:10.1001/jama.2025.4347 · Cited by 369
Self-citationCONSORT 2025 statement: updated guideline for reporting randomized trials
Hopewell, S., Chan, A.-W., Collins, G. S., Hróbjartsson, A., Moher, D., Schulz, K. F., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03635-5 · Cited by 283
Self-citation
Metadata
- Authors
- Hopewell, S., Boutron, I., Chan, A.-W., Collins, G. S., de Beyer, J. A., Hróbjartsson, A., Nejstgaard, C. H., Østengaard, L., Schulz, K. F., Tunn, R., & Moher, D.
- Affiliations
- University of Oxford (GB)
- Inserm (FR)
- University of Toronto (CA)
- University of Southern Denmark (DK)
- University of North Carolina at Chapel Hill (US)
- Ottawa Hospital Research Institute (CA)
- Corresponding author
- Hopewell, Sally
- ORCID
- Venue
- Nature Medicine
- Published
- 2022-09
- Volume
- 28
- Issue
- 9
- Pages
- 1740-1743
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W4295929825
- Cited by
- 127
- References
- 22
- Citations by year
- 2026: 8 · 2025: 57 · 2024: 38 · 2023: 18 · 2022: 5
- FWCI
- 17.81
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- HAL (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- UNC Libraries
- Funders
- RCUK | Medical Research Council (MR/W020483/1)
- Topics
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Keywords
- alcoholic beverages, CONSORT, reporting guidelines, randomized controlled trials, trial reporting quality, clinical trial design, transparency, health interventions
- MeSH terms
- Publishing, Research Design, Randomized Controlled Trials as Topic, Checklist
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An update to SPIRIT and CONSORT reporting guidelines to enhance transparency in randomized trials. https://app.cochat.ai/papers/10.1038/s41591-022-01989-8
- The paper
- Hopewell, S., Boutron, I., Chan, A.-W., Collins, G. S., de Beyer, J. A., Hróbjartsson, A., Nejstgaard, C. H., Østengaard, L., Schulz, K. F., Tunn, R., & Moher, D. (2022). An update to SPIRIT and CONSORT reporting guidelines to enhance transparency in randomized trials. Nature Medicine. https://doi.org/10.1038/s41591-022-01989-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.